Wednesday 12 June 2019

Artificial Vital Organs and Medical Bionics Market Growth 2019-2024


The artificial organs are devices implanted or integrated into a human body in order to replace a natural organ, for the purpose of duplicating or augmenting a specific function or a group of related functions for the patient to return to a normal life as soon as possible, whereas bionics is the application of biological methods and systems found in nature to the study and design of engineering systems and modern technology. The increasing mortality rate of patients awaiting organ transplant has intensified the demand for artificial organs. The artificial vital organs and medical bionics market is undergoing impressive growth across the globe due to increase in the gap between patients awaiting organ transplant and the availability of donor organs.
According to this study, over the next five years the Artificial Vital Organs and Medical Bionics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artificial Vital Organs and Medical Bionics business, shared in Chapter 3.
Report Sample includes:
– Table of Contents
– List of Tables & Figures
– Charts
– Research Methodology

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Vital Organs and Medical Bionics market by product type, application, key manufacturers and key regions and countries.
This study considers the Artificial Vital Organs and Medical Bionics value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
  • Artificial Vital Organs
  • Bionics
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
  • Hospitals
  • Clinics
  • Others
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  • Abbott
  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter
  • Cyberonics, Inc.
  • Edwards
  • Ekso Bionics
  • Roche
  • Fresenius
  • Gambro
  • Iwalk
  • Jarvik Heart
  • Medtronic
  • Micromed Cardiovascular
  • Nikkiso
  • Ossur Hf
  • Ottobock
  • Second Sight Medical Products, Inc.
  • Syncardia Systems, Inc.
  • Thoratec Corporation
  • Touch Bionics, Inc.
  • Vital Therapies, Inc.
  • WorldHeart Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
  • To study and analyze the global Artificial Vital Organs and Medical Bionics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  • To understand the structure of Artificial Vital Organs and Medical Bionics market by identifying its various subsegments.
  • Focuses on the key global Artificial Vital Organs and Medical Bionics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Artificial Vital Organs and Medical Bionics with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Artificial Vital Organs and Medical Bionics submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

No comments:

Post a Comment